People who have both been vaccinated and had Covid-19 are less likely to report fatigue and other health problems seen post Covid, than unvaccinated people, according to a study based in Israel.
The study, not yet peer reviewed, showed that vaccinated people were no more likely to report symptoms than people who have never caught SARS-CoV-2, Nature reported.
The findings showed that fully vaccinated participants who also had Covid-19 were 54 per cent less likely to report headaches, 64 per cent less likely to report fatigue, and 68 per cent less likely to report muscle pain than were their unvaccinated counterparts.
"Here is another reason to get vaccinated, if you needed one," co-author Michael Edelstein, an epidemiologist at Bar-Ilan University in Safed, Israel was quoted as saying.
People with the debilitating condition called long Covid continue to experience symptoms -- such as fatigue, shortness of breath and even trouble concentrating -- weeks, months or years after SARS-CoV-2 infection.
Some estimate that up to 30 per cent of infected people, including many who were never hospitalised, have persistent symptoms.
Vaccination reduces long Covid's incidence by preventing people from getting infected in the first place.
In theory, the shots could also protect against the condition by minimising the length of time the virus has free rein in the body during breakthrough infections.
In the study, the team between July and November 2021, asked more than 3,000 people whether they were experiencing the most common symptoms of long Covid. All had been tested for SARS-CoV-2 between March 2020 and the study period.
The researchers compared the prevalence of each symptom to self-reported vaccination status.
According to Edelstein, his team's study is the most "comprehensive and precise" to date on vaccination and long Covid. He added that the results echo those of other research, including a UK-based study from last September that found that vaccination halved the risk of long Covid, the report said.
--IANS
rvt/vd
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)